Related Experiment Video
Updated: May 14, 2026

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance
M Edip Gurol1, Anand Viswanathan, Christopher Gidicsin
1Hemorrhagic Stroke Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Department of Biostatistics, Harvard School of Public Health, Boston, MA.
Objective:
We hypothesized that vascular amyloid contributes to chronic brain ischemia, therefore amyloid burden measured by Pittsburgh compound B retention on positron emission tomography (PiB PET) would correlate with the extent of magnetic resonance imaging (MRI) white matter hyperintensities (WMH; or leukoaraiosis) in patients with high vascular amyloid deposition (cerebral amyloid angiopathy [CAA]) but not in patients with high parenchymal amyloid deposition (Alzheimer disease [AD]; mild cognitive impairment [MCI]) or in healthy elderly (HE) subjects.
Methods:
Forty-two nondemented CAA patients, 50 HE subjects, and 43 AD/MCI patients had brain MRI and PiB PET. Multivariate linear regression was used to assess the independent association between PiB retention and white matter disease volume, controlling for age, gender, apolipoprotein E genotype, and vascular risk factors within each group.
Results:
CAA patients were younger than HE and AD subjects (68 ± 10 vs 73.3 ± 7 and 74 ± 7.4, p < 0.01) but had higher amounts of WMH (median = 21 vs 3.2 and 10.8 ml, respectively, p < 0.05 for both comparisons). Global PiB retention and WMH showed strong correlation (rho = 0.52, p < 0.001) in the CAA group but not in HE or AD. These associations did not change in the multivariate models. Lobar microbleed count, another marker of CAA severity, also remained as an independent predictor of WMH volume.
Interpretation:
Our results indicate that amyloid burden in CAA subjects (with primarily vascular amyloid) but not AD subjects (with primarily parenchymal amyloid) independently correlates with WMH volume. These findings support the idea that vascular amyloid burden directly contributes to chronic cerebral ischemia and highlights the possible utility of amyloid imaging as a marker of CAA severity.
Insights
Vascular amyloid burden, measured by Pittsburgh compound B (PiB) PET, correlates with white matter hyperintensities (WMH) in cerebral amyloid angiopathy (CAA) patients. This suggests amyloid contributes to chronic brain ischemia in CAA but not Alzheimer disease.
Area of Science:
- Neurology
- Neuroimaging
- Amyloidosis
Background:
- Chronic brain ischemia, indicated by white matter hyperintensities (WMH), is a significant neurological concern.
- Amyloid deposition is implicated in various neurological conditions, including cerebral amyloid angiopathy (CAA) and Alzheimer disease (AD).
- The relationship between amyloid burden and WMH requires further elucidation, particularly differentiating between vascular and parenchymal amyloidosis.
Purpose of the Study:
- To investigate the correlation between amyloid burden, measured by Pittsburgh compound B (PiB) positron emission tomography (PET), and the extent of WMH on magnetic resonance imaging (MRI).
- To determine if this correlation differs between patients with predominant vascular amyloid (CAA) and those with predominant parenchymal amyloid (AD/MCI), as well as healthy elderly (HE) individuals.
Main Methods:
- A cohort of 42 nondemented CAA patients, 50 HE subjects, and 43 AD/MCI patients underwent brain MRI and PiB PET.
- Multivariate linear regression analysis was employed to assess the independent association between PiB retention and WMH volume.
- Analyses controlled for age, gender, apolipoprotein E genotype, and vascular risk factors.
Main Results:
- CAA patients exhibited significantly higher WMH volumes compared to HE and AD/MCI groups, despite being younger.
- A strong positive correlation was observed between global PiB retention and WMH volume in the CAA group (rho = 0.52, p < 0.001).
- This correlation was not significant in the HE or AD/MCI groups, and lobar microbleed count independently predicted WMH volume in CAA patients.
Conclusions:
- Amyloid burden independently correlates with WMH volume in CAA patients, suggesting vascular amyloid directly contributes to chronic cerebral ischemia.
- The findings support the hypothesis that vascular amyloid, not parenchymal amyloid, is associated with WMH in this context.
- Amyloid imaging may serve as a valuable marker for assessing CAA severity and its impact on brain health.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Cerebral Edema ll: Pathophysiology
